SCHEMBL2741564

SCHEMBL2741564

Cc1ccc(-c2ccc(C(F)(F)Oc3cc(F)c(F)c(F)c3)cc2)c(F)c1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 4/20 0.39
AKR1C2 P52895 4/20 0.39
APP P05067 3/20 0.38
GPR3 P46089 1/20 0.35
KIF11 P52732 1/20 0.34
ALOX5AP P20292 1/20 0.33
FEN1 P39748 1/20 0.33
CYP2C19 P33261 1/20 0.33
GRM2 Q14416 1/20 0.33
PDE3B Q13370 3/20 0.32
PDE3A Q14432 3/20 0.32
RORC P51449 2/20 0.32
GRM5 P41594 1/20 0.32
KDM1A O60341 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25808495 0.93 ALOX5AP (0.39) AKR1C3AKR1C2APPGPR3KIF11
SCHEMBL20380692 0.93 AKR1C3 (0.34) AKR1C3AKR1C2APPGPR3GRM2
SCHEMBL16866174 0.92 AKR1C3 (0.37) AKR1C3AKR1C2APPKIF11ALOX5AP
SCHEMBL18735548 0.91 AKR1C3 (0.33) AKR1C3AKR1C2APPGPR3ALOX5AP
SCHEMBL20380670 0.90 PTGS2 (0.34) AKR1C3AKR1C2APPGPR3KDM1A
SCHEMBL18355958 0.89 APP (0.38) AKR1C3AKR1C2APPGPR3KIF11
SCHEMBL17371157 0.87 ALOX5AP (0.38) AKR1C3AKR1C2APPGPR3KIF11
SCHEMBL4432399 0.87 PTPN5 (0.34) CYP2C19
SCHEMBL20380602 0.85 AKR1C3 (0.32) AKR1C3AKR1C2APPGPR3KDM1A
SCHEMBL18887655 0.85 PDE3B (0.33) AKR1C3AKR1C2APPGPR3ALOX5AP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043781-B2 Liquid-crystalline medium MERCK PATENT GMBH (DE) 2024-07-23 US disclosed
US-20230383186-A1 LIQUID-CRYSTAL MEDIUM MERCK PATENT GMBH (DE) 2023-11-30 US disclosed
US-20230383186-A1 LIQUID-CRYSTAL MEDIUM MERCK PATENT GMBH (DE) 2023-11-30 US disclosed
US-11739267-B2 LC medium MERCK PATENT GMBH (DE) 2023-08-29 US disclosed
US-11739267-B2 LC medium MERCK PATENT GMBH (DE) 2023-08-29 US disclosed
US-11739266-B2 Polymerisable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2023-08-29 US disclosed
US-11718791-B2 Polymerisable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2023-08-08 US disclosed
US-11685863-B2 Polymerisable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2023-06-27 US disclosed
US-20230007940-A1 LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCKP PATENT GMBH (DE) 2023-01-12 US disclosed
US-11015121-B2 Liquid crystal displays and liquid crystalline media with homeotropic alignment MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2021-05-25 US disclosed
US-20100224827-A1 LIQUID-CRYSTALLINE MEDIUM WITTEK MICHAEL 2010-09-09 US disclosed
US-7763329-B2 Liquid-crystalline medium MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2010-07-27 US disclosed
US-20100181533-A1 Liquid-crystal compounds and LC media MERCK KGAA (DE) 2010-07-22 US disclosed
US-7658978-B2 Liquid crystalline medium MERCK PATENT GESELLSCHAFT (DE) 2010-02-09 US disclosed
US-20100026953-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GESELLSCHAFT (DE) 2010-02-04 US disclosed
US-20090289223-A1 LIQUID-CRYSTALLINE MEDIUM WITTEK MICHAEL 2009-11-26 US disclosed
US-7595101-B2 Liquid-crystalline medium MERCK PATENT GMBH (DE) 2009-09-29 US disclosed
US-20090230354-A1 Liquid Crystalline Medium MERCK PATENT GESELLSCHAFT (DE) 2009-09-17 US disclosed
WO-2009033564-A2 ELECTRO-OPTICAL LIGHT CONTROL ELEMENT, ELECTRO-OPTICAL DISPLAY AND CONTROL MEDIUM MERCK PATENT GMBH (DE) 2009-03-19 WO disclosed
US-20080083904-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11718791-B2 Polymerisable compounds and the use thereof in liquid-crystal displays VCL, ILK, LCP1 AKR1C3 4067/4885AKR1C2 4097/4885APP 1164/4885
US-11685863-B2 Polymerisable compounds and the use thereof in liquid-crystal displays LPXN, VCL, LCP1 AKR1C3 3514/4885AKR1C2 3386/4885APP 482/4885
US-20080083904-A1 LIQUID-CRYSTALLINE MEDIUM NEFM, OSBP, ALPG AKR1C3 4649/4885AKR1C2 4664/4885APP 864/4885
US-20100181533-A1 Liquid-crystal compounds and LC media VCL, LCT, NEFM AKR1C3 3749/4885AKR1C2 4054/4885APP 1778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.